login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ABBVIE INC (ABBV) Stock News
USA
- NYSE:ABBV -
US00287Y1091
-
Common Stock
227.54
USD
-0.49 (-0.21%)
Last: 10/28/2025, 5:35:16 PM
227.54
USD
0 (0%)
After Hours:
10/28/2025, 5:35:16 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ABBV Latest News, Press Relases and Analysis
All
Press Releases
10 hours ago - By: The Motley Fool
- Mentions:
SCHD
MO
KO
SCHW
...
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever.
12 hours ago - By: The Motley Fool
- Mentions:
ABT
APP
Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You?
a day ago - By: Benzinga
- Mentions:
CAR
CMG
PYPL
CVX
...
Retail Investors' Top Stocks With Earnings This Week: SoFi, Apple, Meta And More
15 days ago - By: Benzinga
If You Invested $100 In AbbVie Stock 10 Years Ago, You Would Have This Much Today
2 days ago - By: Yahoo Finance
- Mentions:
MSFT
AMZN
AAPL
XOM
...
Big Tech earnings, a crucial Fed meeting, and a Trump-Xi sit-down: What to watch this week
7 days ago - By: AbbVie
The Confidence Project by BOTOX® Cosmetic (onabotulinumtoxinA) Unveils This Year's Grant Recipients
8 days ago - By: Zacks Investment Research
- Mentions:
AZN
PFE
MRK
Here's What to Expect From AbbVie's Oncology Segment in Q3 Earnings
8 days ago - By: AbbVie
RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor
11 days ago - By: Stocktwits
- Mentions:
NVO
Novo Nordisk Hires US Pharma Veteran After Trump Touts ‘Much Lower’ Prices Of Ozempic
11 days ago - By: AbbVie
AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin
15 days ago - By: Zacks Investment Research
- Mentions:
AZN
PFE
LLY
AZN Strikes Drug Pricing Deal With Trump, Gets 3-Year Tariff Reprieve
15 days ago - By: Stocktwits
- Mentions:
JGRO
DUHP
AbbVie Stock Rises After FDA Approves Changed Recommendations For Use Of Popular Rinvoq Drug
15 days ago - By: AbbVie
U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ® (upadacitinib) for the Treatment of Inflammatory Bowel Disease
15 days ago - By: AbbVie
AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors
Please enable JavaScript to continue using this application.
